摘要
目的:阐述苓甘五味姜辛夏汤加减治疗神经外科重症监护(Neurosurgical Intensive Care,NICU)患者多重耐药菌肺部感染的临床体会。方法:将近年来武汉市武昌医院与六安市中医院NICU多重耐药菌肺部感染38例患者分为治疗组17例与对照组21例,均按现代医学理论指导治疗,治疗组以温化痰饮为主辨证论治,比较两组气管切开时间、重症监护时间、总住院时间等。结果:与对照组相比较,治疗组患者总住院时间、高热波动时间、NICU监护时间缩短,其中NICU监护时间明显缩短,差异有统计学意义(P <0.05)。结论:以"病痰饮者,当以温药和之"为指导,苓甘五味姜辛夏汤加减治疗多重耐药菌肺部感染患者有效。
Objective: To describe the clinical experience of Linggan Wuwei Jiang Xinxia decoction(苓甘五味姜辛夏汤) in the treatment of pulmonary infection with multiple drug-resistant bacteria in patients with NICU. Methods: 38 patients with NICU multiple drug-resistant bacteria pulmonary infection in Wuchang Hospital of Wuhan City and Traditional Chinese Hospital Hospital of Lu’an in recent years were divided into the treatment group(17 cases) and the control group(21 cases). According to the guidance of modern medical theory, the treatment group was treated with warm phlegm treatment as the main syndrome differentiation, and the tracheotomy time, intensive care time and total hospitalization time were compared between the two groups. Results: Compared with the control group, the total hospitalization time, high fever fluctuation time and NICU monitoring time in the treatment group were shortened, and the NICU monitoring time was significantly shorter than that in the control group(P < 0.05). Conclusion: Modified Linggan Wuwei Jiang Xinxia decoction is effective in the treatment of pulmonary infection caused by multiple drug-resistant bacteria under the guidance of "Those who suffer from phlegm and fluid should be harmonized with warm drug".
作者
文明
刘智明
杨先清
Wen Ming;Liu Zhiming;Yang Xianqing
出处
《中医临床研究》
2020年第18期62-64,共3页
Clinical Journal Of Chinese Medicine
基金
安徽省中医药管理局中医药科研计划项目(2012ZY105)。
关键词
多重耐药菌
肺部感染
痰饮
Multi-drug Resistant Bacteria
Pulmonary infection
Phlegm and Fluid